Works by Murakami, Haruyasu


Results: 140
    1
    2
    3
    4
    5

    Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 6, p. 1165, doi. 10.1007/s00280-009-0979-8
    By:
    • Yamamoto, Noboru;
    • Tamura, Tomohide;
    • Yamamoto, Nobuyuki;
    • Yamada, Kazuhiko;
    • Yamada, Yasuhide;
    • Nokihara, Hiroshi;
    • Fujiwara, Yutaka;
    • Takahashi, Toshiaki;
    • Murakami, Haruyasu;
    • Boku, Narikazu;
    • Yamazaki, Kentaro;
    • Puchalski, Thomas A.;
    • Shin, Eisei
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1736, doi. 10.1093/jjco/hyab158
    By:
    • Wakuda, Kazushige;
    • Yabe, Michitoshi;
    • Kodama, Hiroaki;
    • Nishioka, Naoya;
    • Miyawaki, Taichi;
    • Miyawaki, Eriko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Shimizu, Tetsuo;
    • Gon, Yasuhiro;
    • Takahashi, Toshiaki
    Publication type:
    Article
    12
    13
    14
    15

    A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy.

    Published in:
    Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 840, doi. 10.1093/jjco/hyx084
    By:
    • Kazuhisa Nakashima;
    • Haruyasu Murakami;
    • Kouichi Yokoyama;
    • Shota Omori;
    • Kazushige Wakuda;
    • Akira Ono;
    • Hirotsugu Kenmotsu;
    • Tateaki Naito;
    • Fumie Nishiyama;
    • Mami Kikugawa;
    • Masayo Kaneko;
    • Yumiko Iwamoto;
    • Satomi Koizumi;
    • Keita Mori;
    • Takeshi Isobe;
    • Toshiaki Takahashi
    Publication type:
    Article
    16
    17
    18
    19
    20

    Evaluation of the Safety and Compliance of 3-Week Cycles of Vinorelbine on Days 1 and 8 and Cisplatin on Day 1 as Adjuvant Chemotherapy in Japanese Patients with Completely Resected Pathological Stage IB to IIIA Non-small Cell Lung Cancer: A ...

    Published in:
    Japanese Journal of Clinical Oncology, 2009, v. 39, n. 3, p. 158
    By:
    • Shukuya, Takehito;
    • Takahashi, Toshiaki;
    • Tamiya, Akihiro;
    • Ono, Akira;
    • Igawa, Satoshi;
    • Tsuya, Asuka;
    • Nakamura, Yukiko;
    • Murakami, Haruyasu;
    • Naito, Tateaki;
    • Kaira, Kyoichi;
    • Endo, Masahiro;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    21

    Impact of Physical Inactivity on the Risk of Disability and Hospitalization in Older Patients with Advanced Lung Cancer.

    Published in:
    Journal of Multidisciplinary Healthcare, 2021, v. 14, p. 1521, doi. 10.2147/JMDH.S311225
    By:
    • Yonenaga, Yusuke;
    • Naito, Tateaki;
    • Okayama, Taro;
    • Kitagawa, Midori;
    • Mitsuhashi, Noriko;
    • Ishii, Takeshi;
    • Fuseya, Hiroshi;
    • Inano, Toshimi;
    • Morikawa, Ayumu;
    • Sugiyama, Miwa;
    • Mori, Keita;
    • Notsu, Akifumi;
    • Kawabata, Takanori;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Tanuma, Akira;
    • Takahashi, Toshiaki
    Publication type:
    Article
    22
    23
    24

    Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2012, v. 30, n. 6, p. 2352, doi. 10.1007/s10637-011-9789-z
    By:
    • Takahashi, Toshiaki;
    • Boku, Narikazu;
    • Murakami, Haruyasu;
    • Naito, Tateaki;
    • Tsuya, Asuka;
    • Nakamura, Yukiko;
    • Ono, Akira;
    • Machida, Nozomu;
    • Yamazaki, Kentaro;
    • Watanabe, Junichiro;
    • Ruiz-Garcia, Ana;
    • Imai, Keiji;
    • Ohki, Emiko;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    25
    26
    27

    Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.

    Published in:
    Supportive Care in Cancer, 2015, v. 23, n. 6, p. 1699, doi. 10.1007/s00520-014-2534-3
    By:
    • Kimura, Madoka;
    • Naito, Tateaki;
    • Kenmotsu, Hirotsugu;
    • Taira, Tetsuhiko;
    • Wakuda, Kazushige;
    • Oyakawa, Takuya;
    • Hisamatsu, Yasushi;
    • Tokito, Takaaki;
    • Imai, Hisao;
    • Akamatsu, Hiroaki;
    • Ono, Akira;
    • Kaira, Kyoichi;
    • Murakami, Haruyasu;
    • Endo, Masahiro;
    • Mori, Keita;
    • Takahashi, Toshiaki;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    28
    29

    Individual-level data on the relationships of progression-free survival and post-progression survival with overall survival in patients with advanced non-squamous non-small cell lung cancer patients who received second-line chemotherapy.

    Published in:
    Medical Oncology, 2014, v. 31, n. 8, p. 1, doi. 10.1007/s12032-014-0088-3
    By:
    • Imai, Hisao;
    • Mori, Keita;
    • Ono, Akira;
    • Akamatsu, Hiroaki;
    • Taira, Tetsuhiko;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Kaira, Kyoichi;
    • Murakami, Haruyasu;
    • Endo, Masahiro;
    • Nakajima, Takashi;
    • Takahashi, Toshiaki
    Publication type:
    Article
    30

    Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer.

    Published in:
    2017
    By:
    • Tateaki Naito;
    • Taro Okayama;
    • Takashi Aoyama;
    • Takuya Ohashi;
    • Yoshiyuki Masuda;
    • Madoka Kimura;
    • Hitomi Shiozaki;
    • Haruyasu Murakami;
    • Hirotsugu Kenmotsu;
    • Tetsuhiko Taira;
    • Akira Ono;
    • Kazushige Wakuda;
    • Hisao Imai;
    • Takuya Oyakawa;
    • Takeshi Ishii;
    • Shota Omori;
    • Kazuhisa Nakashima;
    • Masahiro Endo;
    • Katsuhiro Omae;
    • Keita Mori
    Publication type:
    journal article
    31

    Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2902-0
    By:
    • Ryo Ko;
    • Hirotsugu Kenmotsu;
    • Masakuni Serizawa;
    • Yasuhiro Koh;
    • Kazushige Wakuda;
    • Akira Ono;
    • Tetsuhiko Taira;
    • Tateaki Naito;
    • Haruyasu Murakami;
    • Mitsuhiro Isaka;
    • Masahiro Endo;
    • Takashi Nakajima;
    • Yasuhisa Ohde;
    • Nobuyuki Yamamoto;
    • Kazuhisa Takahashi;
    • Toshiaki Takahashi
    Publication type:
    Article
    32

    Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
    By:
    • Nosaki, Kaname;
    • Yoh, Kiyotaka;
    • Toyozawa, Ryo;
    • Horinouchi, Hidehito;
    • Morise, Masahiro;
    • Ohashi, Kadoaki;
    • Murakami, Haruyasu;
    • Satouchi, Miyako;
    • Sakakibara-Konishi, Jun;
    • Yano, Seiji;
    • Okumura, Fumihiko;
    • Matsumoto, Shingo;
    • Shimokawa, Mototsugu;
    • Seto, Takashi;
    • Goto, Koichi
    Publication type:
    Article
    33

    Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 96, doi. 10.1007/s10147-023-02451-6
    By:
    • Wakuda, Kazushige;
    • Morita, Meiko;
    • Sekikawa, Motoki;
    • Morikawa, Noboru;
    • Miura, Keita;
    • Doshita, Kosei;
    • Iida, Yuko;
    • Kodama, Hiroaki;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Ko, Ryo;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Muramatsu, Koji;
    • Kawata, Takuya;
    • Mori, Keita;
    • Shimizu, Tetsuo;
    • Gon, Yasuhiro
    Publication type:
    Article
    34

    Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 6, p. 1025, doi. 10.1007/s10147-022-02151-7
    By:
    • Harada, Hideyuki;
    • Omori, Shota;
    • Mori, Keita;
    • Konno, Masahiro;
    • Murakami, Haruyasu;
    • Imagumbai, Toshiyuki;
    • Fukuda, Haruyuki;
    • Nakamatsu, Kiyoshi;
    • Kimura, Tomoki;
    • Tanabe, Hiroaki;
    • Fujita, Hideki;
    • Tatebe, Hitoshi;
    • Fujitaka, Kazunori;
    • Nishimura, Yasumasa
    Publication type:
    Article
    35

    Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 659, doi. 10.1007/s10147-020-01856-x
    By:
    • Mamesaya, Nobuaki;
    • Muramatsu, Koji;
    • Yabe, Michitoshi;
    • Kodama, Hiroaki;
    • Nishioka, Naoya;
    • Miyawaki, Taichi;
    • Miyawaki, Eriko;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Harada, Hideyuki;
    • Sugino, Takashi;
    • Shimizu, Tetsuo;
    • Gon, Yasuhiro;
    • Takahashi, Toshiaki
    Publication type:
    Article
    36

    Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1052, doi. 10.1007/s10147-018-1305-4
    By:
    • Omori, Shota;
    • Kenmotsu, Hirotsugu;
    • Abe, Masato;
    • Watanabe, Reiko;
    • Sugino, Takashi;
    • Kobayashi, Haruki;
    • Nakashima, Kazuhisa;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Taira, Tetsuhiko;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Ohde, Yasuhisa;
    • Endo, Masahiro;
    • Akiyama, Yasuto;
    • Nakajima, Takashi;
    • Takahashi, Toshiaki
    Publication type:
    Article
    37
    38

    The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 668, doi. 10.1007/s10147-014-0761-8
    By:
    • Ko, Ryo;
    • Kenmotsu, Hirotsugu;
    • Hisamatsu, Yasushi;
    • Akamatsu, Hiroaki;
    • Omori, Shota;
    • Nakashima, Kazuhisa;
    • Oyakawa, Takuya;
    • Wakuda, Kazushige;
    • Shukuya, Takehito;
    • Ono, Akira;
    • Imai, Hisao;
    • Taira, Tetsuhiko;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Mori, Keita;
    • Endo, Masahiro;
    • Ohde, Yasuhisa;
    • Takahashi, Kazuhisa;
    • Takahashi, Toshiaki
    Publication type:
    Article
    39

    Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 1, p. 63, doi. 10.1007/s10147-012-0509-2
    By:
    • Tokito, Takaaki;
    • Kenmotsu, Hirotsugu;
    • Watanabe, Reiko;
    • Ito, Ichiro;
    • Shukuya, Takehito;
    • Ono, Akira;
    • Nakamura, Yukiko;
    • Tsuya, Asuka;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Takahashi, Toshiaki;
    • Ohde, Yasuhisa;
    • Kondo, Haruhiko;
    • Endo, Masahiro;
    • Kameya, Toru;
    • Nakajima, Takashi;
    • Mori, Keita;
    • Yamamoto, Nobuyuki
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47

    Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 2, p. 1633, doi. 10.1007/s00520-021-06572-4
    By:
    • Miyawaki, Taichi;
    • Naito, Tateaki;
    • Yabe, Michitoshi;
    • Kodama, Hiroaki;
    • Nishioka, Naoya;
    • Miyawaki, Eriko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Mori, Keita;
    • Harada, Hideyuki;
    • Takahashi, Kazuhisa;
    • Takahashi, Toshiaki
    Publication type:
    Article
    48

    Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3961, doi. 10.1007/s00520-020-05953-5
    By:
    • Okayama, Taro;
    • Naito, Tateaki;
    • Yonenaga, Yusuke;
    • Ohashi, Takuya;
    • Kitagawa, Midori;
    • Mitsuhashi, Noriko;
    • Ishi, Takeshi;
    • Fuseya, Hiroshi;
    • Aoyama, Takashi;
    • Notsu, Akifumi;
    • Mori, Keita;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Tanuma, Akira
    Publication type:
    Article
    49

    Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.

    Published in:
    Thoracic Cancer, 2024, v. 15, n. 25, p. 1831, doi. 10.1111/1759-7714.15403
    By:
    • Doshita, Kosei;
    • Naito, Tateaki;
    • Matsuda, Suguru;
    • Morita, Meiko;
    • Sekikawa, Motoki;
    • Miura, Keita;
    • Kodama, Hiroaki;
    • Yabe, Michitoshi;
    • Morikawa, Noboru;
    • Iida, Yuko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Ko, Ryo;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Murakami, Haruyasu;
    • Kenmotsu, Hirotsugu;
    • Takahashi, Toshiaki
    Publication type:
    Article
    50